Capricor Therapeutics saw a significant drop in its shares, with a decline of 41% to $3.44, following the company's decision to enter into definitive agreements with commercial partner Nippon Shinyaku and funds associated with Highbridge Capital Management. The agreements pertain to the issuance and sale of 4.9 million shares in a registered direct offering. Each share in the offering includes a warrant to purchase one additional share at an exercise price of $5.70 per share.
Warrant Details and Expiration
The warrants included in the offering will become exercisable six months after issuance and will remain valid for a period of seven years from the date of issuance. The combined offering price per share, including the accompanying warrant, is $4.66.
Timing and Expected Proceeds
The closing of the offering is expected to take place on or around Tuesday. Capricor Therapeutics anticipates generating proceeds of $23 million through this offering. The company intends to allocate these funds towards research and development activities related to its product candidates, manufacturing operations, working capital, and other general corporate purposes.
Positive Meeting with FDA
In another development earlier on Friday, Capricor Therapeutics disclosed that it had a positive type-B meeting with the Food and Drug Administration (FDA). The purpose of the meeting was to discuss the pathway for submitting a biologics license application for CAP-1002, a therapy currently in late-stage clinical development for the treatment of Duchenne muscular dystrophy.
Related Articles
![Japanese Audio Production Company, BloomZ, to Sell 1.25 Million Shares in IPO](https://www.signalsforex.net/img/0888b08e-b978-43c0-bdb4-4db1785eb1d5/news-article-3.jpeg?fm=jpg&q=80&fit=max&crop=1440%2C1080%2C240%2C0)
Japanese Audio Production Company, BloomZ, to Sell 1.25 Million Shares in IPO
Japanese audio production company, BloomZ, announces plans to sell 1.25 million shares in its IPO for $4 per share, aiming to generate $3.22 million. The funds...
![Wall Street's Bullish Call on Tesla](https://www.signalsforex.net/img/0888b08e-b978-43c0-bdb4-4db1785eb1d5/news-article-3.jpeg?fm=jpg&q=80&fit=max&crop=1440%2C1080%2C240%2C0)
Wall Street's Bullish Call on Tesla
An analyst at Wedbush raises price target on Tesla, predicting market share growth and stabilization of margins, despite skepticism from others on Wall Street.
![Netflix Faces Potential Risks as Growth Slows](https://www.signalsforex.net/img/0888b08e-b978-43c0-bdb4-4db1785eb1d5/news-article-3.jpeg?fm=jpg&q=80&fit=max&crop=1440%2C1080%2C240%2C0)
Netflix Faces Potential Risks as Growth Slows
Netflix's growth may have peaked, according to Citi analysts, who point to potential risks such as optimistic revenue estimates, increased content investments,...